Quantcast
Last updated on April 18, 2014 at 9:56 EDT

Latest Pulmonology Stories

2013-05-21 08:29:37

Boehringer Ingelheim also presents new data from a Phase 2 study demonstrating increased bronchodilation with 5 mcg tiotropium as an add-on therapy in symptomatic patients with moderate persistent asthma at the American Thoracic Society International Conference (ATS 2013) RIDGEFIELD, Conn., May 21, 2013 /PRNewswire/ -- Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of...

2013-05-20 23:17:53

Non-Invasive Drug for TB Proves Effective in Easing Painful Effusion, Symptom of Late Stage Mesothelioma DALLAS (PRWEB) May 20, 2013 Chinese researchers have inadvertently stumbled on an effective, non-invasive treatment for easing pleural effusion, a distressing syndrome typical in advanced mesothelioma and other respiratory cancers. Formerly a standardized treatment for tuberculosis, the combination of four anti-bacterial drugs alleviated coughing and breathing difficulty in a 54-year-old...

2013-05-20 08:28:08

BURLINGTON, Mass., May 20, 2013 /PRNewswire/ -- Tomophase Corporation, a leading developer of minimally invasive optical coherence tomography (OCT) tissue imaging devices, announced today that the Thoraxklinik at the University of Heidelberg, Germany has taken the first OCTIS images in clinical patients with the Tomophase OCT Imaging System (OCTIS(TM)) (Photo: http://photos.prnewswire.com/prnh/20130520/PH16298-a) (Photo: http://photos.prnewswire.com/prnh/20130520/PH16298LOGO-b) On...

2013-05-20 08:27:34

--Demonstration of ASM-024 adjunctive benefit with current treatments in pre-clinical asthma models-- QUEBEC CITY, May 20, 2013 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced presentations of four studies of ASM-024, Asmacure's lead compound in development for asthma and chronic obstructive pulmonary disease...

2013-05-20 08:25:53

MADISON, Wis., May 20, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-o-lis), the FDA-cleared mobile health solution for asthma and COPD, today announced CEO David Van Sickle will give an invited presentation during Respiratory Drug Delivery (RDD(®)) Europe 2013 in Berlin, Germany. On Friday, May 24 at 8:30 a.m., Van Sickle will present "Monitoring and Improving Compliance and Asthma Control: Mapping Inhaler Use for Feedback to Patients, Physicians and Payers" as part of the session track,...

2013-05-17 08:23:49

Data on investigational compounds and an approved product will be presented RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- Boehringer Ingelheim will contribute to advancing the scientific discussion in respiratory disease at the American Thoracic Society International Conference (ATS 2013) in Philadelphia, PA, May 17 - 22.( )Data will highlight research conducted with a product approved for the treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler®...

2013-05-17 08:23:25

Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray will become the only available short-acting bronchodilator offering two different medicines in a single inhaler RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- As part of the company's commitment to chronic obstructive pulmonary disease (COPD) patients, Boehringer Ingelheim Pharmaceuticals, Inc., a leader in respiratory health, is updating healthcare professionals (HCPs) and patients that the transition...

2013-05-16 23:30:57

To celebrate Asthma Awareness Month, CascadeBreath of Bend, OR is offering $100 off all Asthma Relief Programs through June 14. It's time to control your asthma and CascadeBreath is prepared to guarantee it. Bend, Oregon (PRWEB) May 16, 2013 May is Asthma Awareness Month and CascadeBreath of Bend, OR is pleased to support the Global Initiative for Asthma's initiative “It's time to control your asthma.” To celebrate this initiative, CascadeBreath is offering $100 off all Asthma...

2013-05-15 23:03:17

Understanding the impact asthma has on women and why it affects them more than men. Fairfax, VA (PRWEB) May 15, 2013 Asthma is a disease that affects people's lungs. Asthma is a disorder that causes the airways of the lungs to swell and narrow, leading to wheezing, shortness of breath, chest tightness, and coughing. When it comes to women and asthma, the ability to breathe can be affected by pregnancy, the menstrual cycle, and menopause. Women who also have allergies and other asthma...

2013-05-15 12:33:29

CLEVELAND, May 15, 2013 /PRNewswire/ -- Simbionix, a world leader in medical simulation, and the American College of Chest Physicians (ACCP), the leader in advanced simulation education, will collaborate to promote bronchoscopy education. This partnership reinforces the goals of both organizations to improve patient safety and outcomes through advanced medical education. (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a ) This deeper commitment follows...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »